Reneo Pharmaceuticals, Inc. Business Finance Contracts & Agreements
10 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (2)
- Registration Rights Agreement dated October 4, 2024 by and among OnKure Therapeutics, Inc. and certain parties thereto (Filed With SEC on October 8, 2024)
- OnKure Therapeutics, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on October 8, 2024)
- Securities Purchase Agreement, dated as of May 2, 2023, by and between Reneo Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP (Filed With SEC on May 5, 2023)
- Underwriting Agreement, dated as of May 3, 2023, by and among Reneo Pharmaceuticals, Inc. and Jefferies LLC, BofA Securities, Inc. and Piper Sandler & Co., as representatives of... (Filed With SEC on May 5, 2023)
- Description of Common Stock of the Registrant (Filed With SEC on March 23, 2022)
- Reneo Pharmaceuticals, Inc. UK Sharesave Sub-Plan to the Reneo Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on November 12, 2021)
- Reneo Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on April 5, 2021)
- Form of Common Stock Certificate (Filed With SEC on April 5, 2021)
- Form of Underwriting Agreement (Filed With SEC on April 5, 2021)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated December 9, 2020 (Filed With SEC on March 19, 2021)
